
—
- Boston, Massachusetts
- February 3, 2022
- www.carb-x.org
Company Information
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With up to US$500 million to invest in 2016-22, CARB-X funds the best science from around the world. The CARB-X portfolio is the world’s largest early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products to prevent, diagnose and treat life-threatening bacterial infections.
Current job openings at Combating Antibiotic Resistant Biopharmaceutical Accelerator (CARB-X)
No job listings found.